{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:54:57Z","timestamp":1781560497283,"version":"3.54.5"},"reference-count":30,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Photomedicine and Laser Surgery"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Objective:<\/jats:italic>\n                    <\/jats:bold>\n                    The purpose of this article was to evaluate the clinical efficacy and safety of a monochromatic 355\u2009nm ultraviolet (UVA) laser in the treatment of vitiligo.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Background data:<\/jats:italic>\n                    <\/jats:bold>\n                    Broadband and narrow-band UV phototherapy has been proposed as an effective therapeutic option in vitiligo patients.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                    <\/jats:bold>\n                    Seventeen consecutive, unselected patients (7 men and 10 women) were enrolled in an open-label, prospective study and treated twice weekly for 8 weeks at a fixed dose of 80\u2013140\u2009J\/cm\n                    <jats:sup>2<\/jats:sup>\n                    . Follow-up was 12 weeks.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                    <\/jats:bold>\n                    Clinical repigmentation was observed in 15\/17 patients (88.23%), with limited side effects (mild post-treatment erythema and itching). Results were maintained during the 12 week phototherapy-free follow-up period.\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                    <\/jats:bold>\n                    the present report suggests that UVA1 laser could be an applicable therapeutic option in patients with vitiligo.\n                  <\/jats:p>","DOI":"10.1089\/pho.2015.4004","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T14:44:17Z","timestamp":1460472257000},"page":"200-204","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["UVA1 Laser in the Treatment of Vitiligo"],"prefix":"10.1177","volume":"34","author":[{"given":"Graziella","family":"Babino","sequence":"first","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Giunta","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Esposito","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Saraceno","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Pavlidis","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Del Duca","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Chimenti","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Paul","family":"Nistic\u00f2","sequence":"additional","affiliation":[{"name":"University of Rome \u201cTor Vergata","place":["Italy"]},{"name":"Magna Graecia University","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0804388"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09091.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2012.12005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0781.2005.00173.x","article-title":"Phototherapy: how does UV work?","volume":"21","author":"Weichental M","year":"2005","unstructured":"Weichental M, , Shwartz T. Phototherapy: how does UV work?. Photodermatol Photoimmunol Photomed, 2005; 21:260\u2013266.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"e_1_3_2_6_2","first-page":"258","article-title":"A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo","volume":"7","author":"Chimento SM","year":"2008","unstructured":"Chimento SM, , Newland M, , Ricotti C, , Nistico S, , Romanelli P. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol, 2008; 7:258\u2013263.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1529-8019.2009.01252.x","article-title":"Monochromatic excimer light 308nm in monotherapy and combined to Khellin 4% in the treatment of vitiligo: results of an open study","volume":"22","author":"Saraceno R","year":"2009","unstructured":"Saraceno R, , Nistic\u00f2 S, , Capriotti E, , Chimenti S. Monochromatic excimer light 308nm in monotherapy and combined to Khellin 4% in the treatment of vitiligo: results of an open study. Dermatol Ther, 2009; 22:391\u2013394.","journal-title":"Dermatol Ther"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/pho.2011.3029","article-title":"Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open controlled randomized study","volume":"30","author":"Nistic\u00f2 S","year":"2012","unstructured":"Nistic\u00f2 S, , Chiricozzi A, , Saraceno R, , Schipani C, , Chimenti S. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open controlled randomized study. Photomed Laser Surg, 2012; 30:26\u201330.","journal-title":"Photomed Laser Surg"},{"key":"e_1_3_2_9_2","first-page":"15","article-title":"Current and emerging therapy for the management of vitiligo","volume":"12","author":"Border\u00e9 AC","year":"2009","unstructured":"Border\u00e9 AC, , Lambert J, , Van Geel N. Current and emerging therapy for the management of vitiligo. Clin Cosmet Investg Dermatol, 2009; 12:15\u201325.","journal-title":"Clin Cosmet Investg Dermatol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2012.3281"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2013.3545"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02035.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof L","year":"2005","unstructured":"Westerhof L, , Niuweboer L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol, 2005; 133:1525\u20131528.","journal-title":"Arch Dermatol"},{"key":"e_1_3_2_14_2","first-page":"25","volume-title":"Photodermatology","author":"Young A","year":"1999","unstructured":"Young A. The molecular and genetic effects of ultraviolet radiation exposure on skin. In: Photodermatology. Hawk JLM (ed.) London: Hodder, Arnold, 1999; pp. 25\u201342."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00474.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1523-1747.2003.12480.x","article-title":"Ultraviolet irradiation induces apoptosis in human immature,but not in skin mast cells","volume":"121","author":"Guhl S","year":"2003","unstructured":"Guhl S, , Hartmann K, , Tapkenhinrichs S, et al. Ultraviolet irradiation induces apoptosis in human immature,but not in skin mast cells. J Invest Dermatol, 2003; 121:837\u2013844.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00403-002-0332-0","article-title":"Apoptosis of human dermal endothelial cells as a potential side effect following therapeutic administration of UVA1 irradiation: preliminary results","volume":"294","author":"Breuckmann F","year":"2002","unstructured":"Breuckmann F, , von Kobyletzki G, , Avermaete A, , Kreuter A, , Mannherz HG, , Altmeyer P. Apoptosis of human dermal endothelial cells as a potential side effect following therapeutic administration of UVA1 irradiation: preliminary results. Arch Dermatol Res, 2002; 294:303\u2013309.","journal-title":"Arch Dermatol Res"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02063.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh643"},{"key":"e_1_3_2_20_2","first-page":"1555","volume-title":"Fitzpatrick's Dermatology in General Medicine","author":"McGregor J","year":"1999","unstructured":"McGregor J, , Hawk J. Acute effects of ultraviolet radiation on the skin. In: Fitzpatrick's Dermatology in General Medicine, 5th ed.,Vol. 134. Freedberg I, , Eisen A, , Wolf K, et al. (eds.). NewYork: McGraw\u2013Hill, 1999, p. 1555","edition":"5"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1523-1747.ep12524813","article-title":"A new apparatus with high radiation energy between 320\u2013460\u2009nm: physical description and dermatological applications","volume":"76","author":"Mutzhas L","year":"1981","unstructured":"Mutzhas L, , Holzle E, , Hofman G, , Plewig G. A new apparatus with high radiation energy between 320\u2013460\u2009nm: physical description and dermatological applications. J Invest Dermatol, 1981; 76:42\u201347.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0781.2011.00643.x","article-title":"Comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo","volume":"28","author":"El Zawahri DM","year":"2012","unstructured":"El Zawahri DM, , Bassiouny DA, , Sobli RM, et al. Comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. Photodermatol Photoimmunol Photomed, 2012; 28:84\u201390.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.jidsp.5640187","article-title":"Ultraviolet A1 (340\u2013400\u2009nm) irradiation and systemic lupus erythematosus","volume":"4","author":"McGrath H","year":"1999","unstructured":"McGrath HJr. Ultraviolet A1 (340\u2013400\u2009nm) irradiation and systemic lupus erythematosus. J Investig Dermatol Symp Proc, 1999; 4:79\u201384.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0198-8859(01)00248-8","article-title":"Ultraviolet-B radiation induces modulation of antigen presentation of herpes simplex virus by human epidermal cells","volume":"62","author":"Van der Molen RG","year":"2001","unstructured":"Van der Molen RG, , Out-Luiting C, , Claas FH, et al. Ultraviolet-B radiation induces modulation of antigen presentation of herpes simplex virus by human epidermal cells. Hum Immunol, 2001; 62:589\u2013597.","journal-title":"Hum Immunol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000051588","article-title":"Bullous pemphigoid in a patient treated with UVA-1 phototherapy for disseminated morphea","volume":"202","author":"Sacher C","year":"2001","unstructured":"Sacher C, , Konig C, , Scharffetter\u2013Kochanek K, et al. Bullous pemphigoid in a patient treated with UVA-1 phototherapy for disseminated morphea. Dermatology, 2001; 202:54\u201357.","journal-title":"Dermatology"},{"key":"e_1_3_2_26_2","first-page":"705","article-title":"Association between UVA1 and PUVA bath therapy and development of malignant melanoma","volume":"52","author":"Wallenfang K","year":"2001","unstructured":"Wallenfang K, , Stadler R. Association between UVA1 and PUVA bath therapy and development of malignant melanoma. Hautarzt, 2001; 52:705\u2013707.","journal-title":"Hautarzt"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3283436e5d"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2009.00656.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/09553000902740150"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0502311102","article-title":"DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene","volume":"102","author":"Besaratinia A","year":"2005","unstructured":"Besaratinia A, , Synold TW, , Chen HH, et al. DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci USA, 2005; 102:10,058\u201310,063.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0781.2007.00284.x","article-title":"Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy","volume":"23","author":"Schnopp C","year":"2007","unstructured":"Schnopp C, , Rad R, , Weidinger A, et al. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy. Photodermatol Photoimmunol Photomed, 2007; 23:81\u201385.","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Photomedicine and Laser Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/pho.2015.4004","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pho.2015.4004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pho.2015.4004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:36:54Z","timestamp":1781559414000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/pho.2015.4004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1089\/pho.2015.4004"],"URL":"https:\/\/doi.org\/10.1089\/pho.2015.4004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726292548.793517081","asserted-by":"object"}]},"ISSN":["1549-5418","1557-8550"],"issn-type":[{"value":"1549-5418","type":"print"},{"value":"1557-8550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}